Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 343-65-7
2. Dl-kynurenine
3. 2-amino-4-(2-aminophenyl)-4-oxobutanoic Acid
4. 3-anthraniloylalanine
5. 3-anthraniloyl-dl-alanine
6. Rac Kynurenine
7. Alanine, 3-anthraniloyl-
8. Kynurenin
9. (+-)-kynurenine
10. (+/-)-kynurenine
11. Alanine, 3-anthraniloyl-, Dl-
12. Chebi:28683
13. 298m20b2au
14. Benzenebutanoic Acid, Alpha,2-diamino-gamma-oxo-
15. Benzenebutanoic Acid, .alpha.,2-diamino-.gamma.-oxo-
16. Alpha-2-diamino-gamma-oxobenzenebutyric Acid
17. Quinurenine
18. 3039-10-9
19. Rac-kynurenine
20. Unii-298m20b2au
21. Einecs 206-445-9
22. Spectrum_001162
23. Kynurenine [mi]
24. Kynurenine, Dl-
25. Specplus_000330
26. 2-amino-4-(2-aminophenyl)-4-oxobutanoic Acid #
27. D-2-amino-4-[2-aminophenyl]-4-oxobutanoic Acid
28. Spectrum2_001380
29. Spectrum3_000781
30. Spectrum4_001916
31. Spectrum5_000632
32. Alpha,2-diamino-gamma-oxobenzenebutanoic Acid
33. Dl-kynurenine, Free Base
34. 2-amino-4-(2-aminophenyl)-4-oxobutanoicacid
35. Schembl20874
36. Bspbio_002482
37. Kbiogr_002539
38. Kbioss_001642
39. Divk1c_006426
40. Spectrum1500879
41. Spbio_001340
42. Chembl1377927
43. Bdbm31880
44. Kbio1_001370
45. Kbio2_001642
46. Kbio2_004210
47. Kbio2_006778
48. Kbio3_001702
49. Kynurenine, (+/-)-
50. Dtxsid90861884
51. Alanine, 3-anthraniloyl- (8ci)
52. Ccg-38856
53. Dl-kynurenine, >=95.0% (nt)
54. Mfcd00025194
55. Stl453545
56. Akos015894416
57. Cs-w015220
58. Hy-w014504
59. Sdccgmls-0066734.p001
60. Dl-kynurenine Sulfate (salt) Monohydrate
61. Ncgc00017339-02
62. Ncgc00017339-03
63. Ncgc00095648-01
64. Ncgc00095648-02
65. As-12298
66. 2-amino-3-(2-aminobenzoyl)propionic Acid
67. Db-006353
68. Db-050656
69. Ft-0600276
70. Ft-0600475
71. Ft-0627925
72. 2-amino-4-(2-aminophenyl)-4-oxobutyric Acid
73. C01718
74. D86788
75. K-9000
76. K-9002
77. .alpha.-2-diamino-.gamma.-oxobenzenebutyric Acid
78. Sr-05000002450
79. Sr-05000002450-1
80. Q32908783
81. Benzenebutanoic Acid, Alpha,2-diamino-gamma-oxo- (9ci)
82. Ad0899ca-9379-461e-bd7d-45908947c589
| Molecular Weight | 208.21 g/mol |
|---|---|
| Molecular Formula | C10H12N2O3 |
| XLogP3 | -2.2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 208.08479225 g/mol |
| Monoisotopic Mass | 208.08479225 g/mol |
| Topological Polar Surface Area | 106 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 255 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Kynurenine Degrading Enzyme manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Kynurenine Degrading Enzyme, including repackagers and relabelers. The FDA regulates Kynurenine Degrading Enzyme manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Kynurenine Degrading Enzyme API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Kynurenine Degrading Enzyme supplier is an individual or a company that provides Kynurenine Degrading Enzyme active pharmaceutical ingredient (API) or Kynurenine Degrading Enzyme finished formulations upon request. The Kynurenine Degrading Enzyme suppliers may include Kynurenine Degrading Enzyme API manufacturers, exporters, distributors and traders.
Kynurenine Degrading Enzyme Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Kynurenine Degrading Enzyme GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Kynurenine Degrading Enzyme GMP manufacturer or Kynurenine Degrading Enzyme GMP API supplier for your needs.
A Kynurenine Degrading Enzyme CoA (Certificate of Analysis) is a formal document that attests to Kynurenine Degrading Enzyme's compliance with Kynurenine Degrading Enzyme specifications and serves as a tool for batch-level quality control.
Kynurenine Degrading Enzyme CoA mostly includes findings from lab analyses of a specific batch. For each Kynurenine Degrading Enzyme CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Kynurenine Degrading Enzyme may be tested according to a variety of international standards, such as European Pharmacopoeia (Kynurenine Degrading Enzyme EP), Kynurenine Degrading Enzyme JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Kynurenine Degrading Enzyme USP).
LOOKING FOR A SUPPLIER?
